Expression of MAGE-C1/CT7 and MAGE-C2/CT10 predicts lymph node metastasis in melanoma patients.
about
Expression of novel cancer/testis antigen TMEM31 increases during metastatic melanoma progression.Targeting MAGE-C1/CT7 expression increases cell sensitivity to the proteasome inhibitor bortezomib in multiple myeloma cell linesBAP31, a promising target for the immunotherapy of malignant melanomas.MicroRNA-874 Functions as a Tumor Suppressor by Targeting Cancer/Testis Antigen HCA587/MAGE-C2.Establishment of MAGEC2-knockout cells and functional investigation of MAGEC2 in tumor cells.MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis.Germ cell proteins in melanoma: prognosis, diagnosis, treatment, and theories on expression.The MAGE protein family and cancer.The cancer/testis antigen MAGEC2 promotes amoeboid invasion of tumor cells by enhancing STAT3 signaling.MAGE-C2-Specific TCRs Combined with Epigenetic Drug-Enhanced Antigenicity Yield Robust and Tumor-Selective T Cell Responses.Cancer-testis antigen MAGEC2 promotes proliferation and resistance to apoptosis in Multiple Myeloma.Expression of cancer-testis antigen in multiple myeloma.Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma.[Expression and significance of MAGE genes in human lung cancer].Expression of cancer/testis antigens MAGE-A, MAGE-C1, GAGE and CTAG1B in benign and malignant thyroid diseases.Melanoma: a prototype of cancer-testis antigen-expressing malignancies.MAGE-C1/CT7 and MAGE-C2/CT10 are frequently expressed in multiple myeloma and can be explored in combined immunotherapy for this malignancy.Cancer testis antigen expression in testicular germ cell tumorigenesis.[Expression and Clinical Significance of MAGE-C2 in Lung Adenocarcinoma].Post-transcriptional regulation of cancer/testis antigen MAGEC2 expression by TRIM28 in tumor cellsCancer/testis antigens (CTAs) expression in resected lung cancer
P2860
Q33597527-41CF2413-D064-4416-9D51-35891F159FD7Q34081748-A7D86418-262F-4E46-9806-AD613E364273Q35518667-1DD3F615-FC93-4BE1-BA65-175AEF68FDEDQ36792348-EABA316E-2F77-4A58-83EC-DED802C43D59Q37544387-F84A9270-3B29-433D-A975-1A60214A0157Q37699127-ABE4BFAC-1C27-444B-9E00-5E1CB7FE75FFQ38064856-A5D20457-B951-4597-A514-08D5CA0364E1Q38581531-4F89A914-3EF7-4FC9-9F2F-175710E97C44Q38738094-3F3E4525-8804-4DF4-BA21-22217569634AQ38753922-8306238C-A355-4D79-ADAF-8FC845028D5DQ38828754-F4F52B3A-D9D9-4A49-9C59-2519DC45150FQ39006726-F60C4E81-FD98-4561-9B92-46DEE7514630Q41569778-AFE258E3-B7CD-4CF6-9BBF-D2FB46AF290EQ43560337-86601312-6F1B-48D9-B00D-397C429945F9Q47199295-F82E17D6-1144-4B69-9F01-789D7660CC7CQ50070352-2D08E194-F619-4643-931E-6E9129370A9FQ54282269-51F98FF1-9B26-484C-9351-40B86F287EE3Q54598067-F01155AC-7BE6-4E33-A71B-04F0085F859FQ55447676-77BFD55C-D56A-4B4A-BFBB-B511C6F250BAQ57474611-35D5A79A-F786-4C82-9F8E-02999B94B805Q58806299-2457802B-3E97-4934-8016-5A54E6FC0F6F
P2860
Expression of MAGE-C1/CT7 and MAGE-C2/CT10 predicts lymph node metastasis in melanoma patients.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Expression of MAGE-C1/CT7 and ...... tastasis in melanoma patients.
@ast
Expression of MAGE-C1/CT7 and ...... tastasis in melanoma patients.
@en
type
label
Expression of MAGE-C1/CT7 and ...... tastasis in melanoma patients.
@ast
Expression of MAGE-C1/CT7 and ...... tastasis in melanoma patients.
@en
prefLabel
Expression of MAGE-C1/CT7 and ...... tastasis in melanoma patients.
@ast
Expression of MAGE-C1/CT7 and ...... tastasis in melanoma patients.
@en
P2093
P2860
P1433
P1476
Expression of MAGE-C1/CT7 and ...... tastasis in melanoma patients.
@en
P2093
Alessandra Curioni-Fontecedro
Alexander Knuth
Daniela Mihic-Probst
Davide Soldini
Holger Moch
Maries van den Broek
Natko Nuber
Reinhard Dummer
P2860
P304
P356
10.1371/JOURNAL.PONE.0021418
P407
P577
2011-06-27T00:00:00Z